Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Thyroid Ca After Hodgkin Lymphoma Evaluated

Leuk Lymphoma; 2017 Sep 1; Chowdhry, et al

Publish date:: September 6, 2017

Even though people with Hodgkin lymphoma (HL) are at significantly greater risk of thyroid cancer, having HL previously is not linked with more aggressive forms of cancer or worse prognosis, according to a study involving nearly 140,000 individuals. Participants had either primary thyroid cancer (n=139,297) or thyroid cancer after HL (n=174). Investigators looked at outcomes in the 2 groups, as well as a possible link between HL history and overall survival after thyroid cancer. Among the results:

HL history was linked with neither anaplastic nor sarcoma thyroid cancer.
There was also no link between HL history and difference in risk of death after thyroid cancer.

Citation:

Chowdhry A, Fung C, Chowdhry V, et al. A population-based study of prognosis and survival in patients with second primary thyroid cancer after Hodgkin lymphoma. [Published online ahead of print September 1, 2017]. Leuk Lymphoma. doi:10.1080/10428194.2017.1369063.

This Week's Must Reads

Phase II Trial of DNA Vaccine Encoding PAP in Patients with PCa ,

Utilization of Surgery for Post-prostatectomy Incontinence,

Claims Analysis of Advanced PCa Treatment Costs and Resource Use,

Testosterone Therapy Doesn't Increase Prostate Cancer Risk,

Clinical Outcomes in Cyclin-dependent Kinase 12 Mutant Advanced PCa,

Must Reads in Lymphoma & Plasma Cell Disorders

Cardiac assessment before doxorubicin treatment , Enns DL et al. Mayo Clin Proc Innov Qual Outcomes. 2018 Aug 3;2(3):277-85

Long-term ibrutinib data in older patients, Barr PM et al. Haematologica. 2018;103(9):1502-10

Outcomes Post-AlloSCT in DHL/DEL Lymphomas, Biol Blood Marrow Transplant; ePub 2017 Nov 28; Herrera, et al

Anthracycline-Related CV Dysfunction Evaluated, Cancer; ePub 2017 Nov 7; Armenian, Mertens, et al

Adcetris Approved for Primary Cutaneous ALCL, FDA news release; 2017 Nov 9